► Sharekhan (Free Demat)

Bafna Pharmaceuticals Ltd IPO Information

Table of Contents

Incorporated in 1995, Bafna Pharmaceuticals Limited is engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The Company manufactures 126 formulations under various therapeutic segments, such as anti-infective, cholesterol lowering agents, analgesic and antipyretic, antihelmintics, appetite stimulants, cough and cold preparations, antiulcerants anti diabetic, and vitamins.

In 2006, Bafna has set up an 100% EOU unit at Madhavaram for the production of tablets and capsule with a capacity of 6973.20 lacs and 2462.40 lacs. The unit has been WHO GMP certified and also ISO 9000 certified. The products manufactured in this factory caters to the markets of Srilanka, Ghana and Ukraine. Bafna was involved in the execution of contracts for the generic division of M/s. Croslands from the period 1994 to 2001. Bafna was awarded the WHO GMP certification during the year 1995. Presently around 57 products of the company are registered in Srilanka, 4 products in Ukraine, 1 product in Ghana. The company received the Best Supplier award from the Srilankan Government during 2005.

Bafna Pharmaceuticals Ltd IPO Information:

»» Public Issue Open: May 27, 2008 to May 30, 2008
»» Public Issue Type: Fixed price
»» Public Issue Size: 64,00,000 Equity Shares of Rs. 10/-
»» Face Value: Rs. 10/-
»» Public Issue Price: Rs 40/-
»» Maximum Subscription Amount for Retail Investor: Rs 100,000/-
»» Listing: BSE
»» Lead Manager: Keynote Corporate Services Ltd, Ashika Capital Ltd
»» Registrar: Cameo Corporate Services Ltd (Ph: +91-44-28460390 Email: [email protected])

Courtesy: chittorgarh.com

Share the Post:

0 Responses

  1. Dear Visitors,

    This blog is really nice and informative. We are pleased to know this blog is really helping people. Its our pleasure to post informative content on this useful blog created by webmaster.

    Now once again as on 02-June-08 around 11.15AM,market is trying to become bit bullish but still we cant rule out profit booking from every rise. Still we suggest everyone to remember this is Indian stock market
    so watch your every step. Avoid going Long until Nifty crosses 5050 mark and avoid going short until nifty breaks 4820. Till then enjoy the consolidation phase and prefer to do intraday trading only.




Leave a Reply

Your email address will not be published. Required fields are marked *